Literature DB >> 24506205

A study of the inhibition of catalase by dipotassium trioxohydroxytetrafluorotriborate K₂[B₃O₃F₄OH].

Safija Islamovic1, Borivoj Galic, Mladen Milos.   

Abstract

In the development of boronic acid-based enzyme inhibitors as potential pharmaceutical drugs, dipotassium trioxohydroxytetrafluorotriborate K2[B3O3F4OH] was listed as a promising new therapeutic for treatment of these diseases. The catalase-mediated conversion of hydrogen peroxide, in the presence and absence of K2[B3O3F4OH] was studied. The kinetics conformed to the Michaelis-Menten model. Lineweaver-Burk plots were linear and plotted the family of straight lines intersected on the abscissa indicating non-competitive inhibition of the catalase. It appears that in the absence of inhibitor, catalase operates the best at conditions around pH 7.1 and in the presence of K2[B3O3F4OH] the optimum is around pH 6.2. The uncatalyzed reaction of hydrogen peroxide decomposition generally has a value of activation energy of 75 kJ mole(-1), whereas catalase, in the absence of inhibitor, lowers the value to 11.2 kJ mole(-1), while in the presence 69 mmoles L(-1) of K2[B3O3F4OH] it was 37.8 kJ mole(-1).

Entities:  

Keywords:  Boroxine; catalase; drug research; enzyme inhibition

Mesh:

Substances:

Year:  2014        PMID: 24506205     DOI: 10.3109/14756366.2013.848203

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  2 in total

1.  Advantages of an Electrochemical Method Compared to the Spectrophotometric Kinetic Study of Peroxidase Inhibition by Boroxine Derivative.

Authors:  Jelena Ostojić; Safija Herenda; Zerina Bešić; Mladen Miloš; Borivoj Galić
Journal:  Molecules       Date:  2017-07-05       Impact factor: 4.411

2.  In vitro and in vivo antitumour effects of phenylboronic acid against mouse mammary adenocarcinoma 4T1 and squamous carcinoma SCCVII cells.

Authors:  Maja Marasovic; Sinisa Ivankovic; Ranko Stojkovic; Damir Djermic; Borivoj Galic; Mladen Milos
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.